You are here: Industry Insights > Vaccine development

News List

Coriolis Pharma Re-Establishes Chair in Vaccine Development at Leiden University B3C newswire
November 16, 2023
Coriolis Pharma Research today announced that the Special Chair in Vaccine Development at Leiden University has been re-awarded to Prof. Dr. Gideon Kersten, Scientific Advisor at Coriolis Pharma.
EIB, CEPI Sign Agreement to Accelerate Infectious Disease Vaccination Development americanpharmaceuticalreview
May 04, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and the European Investment Bank (EIB) signed an advisory agreement to collaborate on the development of innovative financing schemes to support vaccines development across the globe.
NIAID strategic plan for COVID-19 focuses on developing assays, therapeutics and vaccines europeanpharmaceuticalreview
April 30, 2020
The US National Institute of Allergy and Infectious Diseases (NIAID) has revealed its research priorities relating to COVID-19, including supporting the development and testing of potential therapeutics and vaccines.
AI can play a big role in vaccine development for COVID-19 expresspharma
April 30, 2020
Many believe that AI has the potential to complement the scientific community in major breakthroughs, especially in developing vaccines for COVID-19.
Government forms high-level task force for COVID-19-related works expresspharma
April 21, 2020
The task force will ensure work progress in the fields of science and vaccine development.
Merck joins TRANSVAC2 programme to advance vaccine development biospectrumasia
May 21, 2019
TRANSVAC2, part of the EU's Horizon 2020 program, provides trainings to streamline vaccine manufacturing and development
Valneva's Lyme vaccine—the only active candidate out there—moves to phase 2 fiercepharma
December 20, 2018
On the back of positive phase 1 data, Valneva has started a phase 2 study on VLA15, currently the only Lyme disease vaccine candidate in active clinical development.
These 20 women are 2018's Fiercest in the life sciences industry. fiercepharma
December 12, 2018
Merck & Co.’s experimental Ebola vaccine rVSV-ZEBOV has been deployed widely in the Democratic Republic of Congo. But experts are calling on the U.S. government to send CDC specialists
Global coalition backs Imperial College London’s RNA vaccine platform to fight ‘Disease X’ fiercepharma
December 11, 2018
One of the first missions that the Coalition for Epidemic Preparedness Innovations (CEPI) set when it came into being in 2017 was to facilitate development of vaccine platforms that can be quickly adopted
Janssen, Merck chip in for $100M U.K. vaccine center to help fight epidemics fiercepharma
December 05, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. government, with help from academic institutions and the pharma industry...

Previous page 1 2 Next page